To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.

Bill 119 HR 661, also known as the United States-Israel Health Care Cooperation Act, aims to establish a program that will promote collaboration between the United States and Israel in the development and delivery of health care products and services. The program will be overseen by the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs.

The goal of this program is to facilitate and coordinate efforts between the two countries to expand and enhance their cooperation in the health care sector. This collaboration will involve sharing knowledge, resources, and expertise to improve the development and delivery of health care products and services.

By working together, the United States and Israel hope to advance medical research, innovation, and technology in the health care field. This partnership will benefit both countries by fostering mutual learning and innovation, ultimately leading to improved health outcomes for their populations. Overall, Bill 119 HR 661 seeks to strengthen the relationship between the United States and Israel in the health care sector, promoting collaboration and innovation for the benefit of both countries.